Chimerix pays $30M to secure rights for late-stage leukemia drug
DURHAM. N.C. – Chimerix has raised nearly $35 million in equity to buy the exclusive global rights to a new drug that can potentially treat a range of blood cancers. This week, the Durham-based biopharmaceutical company announced an agreement with Cantex Pharmaceuticals for the worldwide license of CX-01. The new chemical entity is derived from the anticoagulant herapin and is being developed to treat acute myeloid leukemia (AML). Under the terms of the deal, Chimeriz will pay Cantex $30 million upfront, up to $587.5 million in milestines, tiered royalties starting at 10 percent and...
Read MoreCell Microsystems raises $1.85M to commercialize single-cell sorting devices
RESEARCH TRIANGLE PARK, N.C. – Cell Microsystems, a developer of devices for biomedical researchers to automate, speed up and reduce the costs of sorting and isolation of single cells for downstream processes such as gene editing, has raised $1.85 million from 12 investors to fund acceleration of its commercial operations. The funding will, in part, enable adding as many as five support, manufacturing and sales personnel by the end of 2019 to its current total of 15 employees, according to CEO Gary Pace, Ph.D., J.D. The company has already installed more than a dozen automated systems...
Read MoreX-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
JUPITER, FL. – X-Vax Technology, Inc. (X-VAX ™), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced that it has raised $56 million in an upsized Series A financing with participation from strategic and institutional investors, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC); Adjuvant Capital, an impact investment fund supported by the Bill & Melinda Gates Foundation as an anchor investor; Serum Institute of India; Alexandria Venture Investments; and FF DSF VI, a scout investment...
Read MoreBiotech startup raises $13M, expands Triangle presence under former BioDelivery Sciences CEO
RESEARCH TRIANGLE PARK, N.C. – ArunA Bio, a bioscience company with a platform technology developing biologic particles called exosomes to treat neurodegenerative disorders, is expanding its footprint into North Carolina – and adding $13 million to its bank account. The company announced this morning that it has completed a $13 million common stock financing from existing and new private investors, along with participation by several institutional investors including Eshelman Ventures, and members of the board of directors and management. ArunA is a spin-out of the University of...
Read MoreGuideWell Innovation Selects Six Women-founded Health Tech Companies for Summer Scale-Up Accelerator Cohort
ORLANDO, FL. – GuideWell Innovation Selects Six Women-founded Health Tech Companies for Summer Scale-Up Accelerator Cohort GuideWell Innovation, in affiliation with Springboard Enterprises, has selected six health technology companies for the Summer 2019 GuideWell Scale-Up Accelerator cohort. The GuideWell Scale-Up Accelerator is an eight-week technology accelerator program focused on “Scale-Up” health technology or medical device companies. This cohort is dedicated to companies with women founders that are headquartered in the southeastern U.S. The southeastern U.S. lags other...
Read MorePiedmont Triad honors ‘Body-on-a-Chip’ team, life science leaders at BioNight
GREENSBORO, N.C. – Some of the Piedmont Triad region’s most successful individuals and organizations working in the biosciences have been honored with Excellence Awards. The awards were given at Triad BioNight, a celebration of the region’s life science sector organized by the Piedmont Triad Office of the North Carolina Biotechnology Center. More than 300 people attended the networking and awards event June 20 at the Grandover Resort and Conference Center in Greensboro. The honorees are: Yonnie Butler Yonnie D. Butler, executive director of the Biotechnology Center of...
Read More
Follow Us!